Recent Progress With CD38 Antibodies to Improve Outcomes in Multiple Myeloma: Expert Guidance for Clinical Practice

Share

Program Content

Activities

  • CD38 Antibodies in MM
    Recent Progress With CD38 Antibodies to Improve Outcomes in Multiple Myeloma: Expert Guidance for Clinical Practice
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: November 09, 2023

Faculty

cover img faculity

Ajai Chari, MD

Director of Multiple Myeloma Program
Professor of Clinical Medicine
University of California- San Francisco
San Francisco, California

cover img faculity

Angela Davies, MD

Assistant Professor of Medicine
UC Davis Cancer Center
Sacramento, CA

cover img faculity

Pritesh Patel, MD

Associate Professor of Clinical Medicine
Division of Hematology/Oncology
Associate Director
Blood and Marrow Transplant Program
University of Illinois at Chicago
Chicago, Illinois

cover img faculity

Saad Z. Usmani, MD, MBA, FACP

Chief of Myeloma Service
Memorial Sloan Kettering Cancer Center
Professor
Weill Cornell Medical College, Cornell University
New York, New York

PT Faculty

cover img faculity

Angela Fleischman, MD, PhD

Assistant Professor
Division of Hematology/Oncology
University of California, Irvine
Irvine, California